Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04654767Recruiting

Inflammatory Profiling in Chronic Lung Disease

Role: lead

NCT04329312Terminated

Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis

Role: collaborator

NCT03030807Completed

Pulmonary Hypertension in Hypersensitivity Pneumonitis

Role: collaborator

NCT02223559Completed

Non-invasive Assessment of Pulmonary Artery Pressure

Role: collaborator

NCT02790450Phase 2Completed

Acute Effects of Benzbromaron on the Pulmonary Circulation

Role: collaborator

NCT02391090Not ApplicableCompleted

FeNO After Hypoxia in Asthma Patients

Role: collaborator

All 6 trials loaded